EP1128839A4 - Compositions pharmaceutiques comprenant des copolymeres de peptides synthetiques et methodes de prevention et de traitement de la reaction du greffon contre l'hote (gvhd) et de la reaction de l'hote contre le greffon (hvgd) - Google Patents
Compositions pharmaceutiques comprenant des copolymeres de peptides synthetiques et methodes de prevention et de traitement de la reaction du greffon contre l'hote (gvhd) et de la reaction de l'hote contre le greffon (hvgd)Info
- Publication number
- EP1128839A4 EP1128839A4 EP99960378A EP99960378A EP1128839A4 EP 1128839 A4 EP1128839 A4 EP 1128839A4 EP 99960378 A EP99960378 A EP 99960378A EP 99960378 A EP99960378 A EP 99960378A EP 1128839 A4 EP1128839 A4 EP 1128839A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- hvgd
- preventing
- methods
- pharmaceutical compositions
- synthetic peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10818498P | 1998-11-12 | 1998-11-12 | |
US108184P | 1998-11-12 | ||
US14521999P | 1999-07-23 | 1999-07-23 | |
US145219P | 1999-07-23 | ||
PCT/US1999/027107 WO2000027417A1 (fr) | 1998-11-12 | 1999-11-12 | Compositions pharmaceutiques comprenant des copolymeres de peptides synthetiques et methodes de prevention et de traitement de la reaction du greffon contre l'hote (gvhd) et de la reaction de l'hote contre le greffon (hvgd) |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1128839A1 EP1128839A1 (fr) | 2001-09-05 |
EP1128839A4 true EP1128839A4 (fr) | 2002-10-09 |
Family
ID=26805609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99960378A Withdrawn EP1128839A4 (fr) | 1998-11-12 | 1999-11-12 | Compositions pharmaceutiques comprenant des copolymeres de peptides synthetiques et methodes de prevention et de traitement de la reaction du greffon contre l'hote (gvhd) et de la reaction de l'hote contre le greffon (hvgd) |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1128839A4 (fr) |
AU (1) | AU775073C (fr) |
CA (1) | CA2355400A1 (fr) |
WO (1) | WO2000027417A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL141021A0 (en) | 1998-07-23 | 2002-02-10 | Yeda Res & Dev | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
ES2527760T3 (es) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
US7022663B2 (en) | 2000-02-18 | 2006-04-04 | Yeda Research And Development Co., Ltd. | Oral, nasal and pulmonary dosage formulations of copolymer 1 |
US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
WO2002076503A1 (fr) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Traitement de maladies du systeme nerveux central au moyen d'anticorps diriges contre l'acetate de glatiramere |
CN1308683C (zh) | 2001-12-04 | 2007-04-04 | 特瓦制药工业有限公司 | 测量醋酸格拉默功效的方法 |
PT1592384E (pt) * | 2003-01-21 | 2013-01-28 | Yeda Res & Dev | Cop-1 para o tratamento de doenças inflamatórias do intestino |
US7655221B2 (en) | 2004-05-07 | 2010-02-02 | Peptimmune, Inc. | Methods of treating disease with random copolymers |
BRPI0510738A (pt) | 2004-05-07 | 2007-11-20 | Peptimmune Inc | métodos de tratar doenças com copolìmeros aleatórios |
SI2361924T1 (sl) | 2004-09-09 | 2014-04-30 | Teva Pharmaceutical Industries Ltd. | Postopek za pripravo zmesi trifluoroacetil glatiramer acetata ob uporabi očiščene bromovodikove kisline |
WO2006029411A2 (fr) | 2004-09-09 | 2006-03-16 | Yeda Research And Development Co. Ltd. | Melanges de polypeptides, compositions les contenant et leurs procedes de preparation et d'utilisation |
DE602005016292D1 (de) | 2004-10-29 | 2009-10-08 | Sandoz Ag | Verfahren zur herstellung von glatiramer |
US20080171070A1 (en) * | 2005-01-31 | 2008-07-17 | Pierre Schaaf | Polyelectrolyte Multilayer Film, Preparation And Uses Thereof |
CA2649296A1 (fr) | 2006-04-13 | 2007-10-25 | Peptimmune, Inc. | Procedes de conception et de synthese de compositions de polymeres a sequence dirigee par expansion dirigee de la permeabilite epitopique |
AU2008311897B2 (en) | 2007-10-16 | 2015-03-26 | Declion Holdings Llc | Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
KR20170123354A (ko) | 2009-08-20 | 2017-11-07 | 에다 리서치 앤드 디벨럽먼트 컴퍼니 리미티드 | 글라티라머 아세테이트를 포함하는 약제 |
US8377885B2 (en) | 2010-01-04 | 2013-02-19 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
TR201818858T4 (tr) | 2010-01-04 | 2019-01-21 | Mapi Pharma Ltd | Glati̇ramer asetat i̇çeren depo si̇stemi̇. |
US8759302B2 (en) | 2010-03-16 | 2014-06-24 | Teva Pharmaceutical Industries, Ltd. | Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
US8709433B2 (en) | 2010-10-11 | 2014-04-29 | Teva Pharmaceutical Industries Ltd. | Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate |
EP2699317B1 (fr) | 2011-04-21 | 2016-08-10 | Mapi Pharma Limited | Pentapolymère statistique pour le traitement de maladies auto-immunes |
WO2013055683A1 (fr) | 2011-10-10 | 2013-04-18 | Teva Pharmaceutical Industries Ltd. | Polymorphismes de nucléotide simple utiles pour prédire une réponse clinique à l'acétate de glatiramère |
US9617596B2 (en) | 2012-10-10 | 2017-04-11 | Teva Pharmaceutical Industries, Ltd. | Biomarkers predictive for clinical response for glatiramer acetate |
UY35790A (es) | 2013-10-21 | 2015-05-29 | Teva Pharma | Marcadores genéticos que predicen la respuesta al acetato de glatiramer |
US9155775B1 (en) | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
US11167003B2 (en) | 2017-03-26 | 2021-11-09 | Mapi Pharma Ltd. | Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992002543A1 (fr) * | 1990-08-01 | 1992-02-20 | Cytel Corporation | Nouveaux peptides immunosuppresseurs |
WO1994026774A1 (fr) * | 1993-05-19 | 1994-11-24 | Cytel Corporation | Nouveaux traitements de maladies allergiques |
WO1995026980A2 (fr) * | 1994-04-01 | 1995-10-12 | Immulogic Pharmaceutical Corporation | Peptides haptines et leurs utilisations |
WO1995031997A1 (fr) * | 1994-05-20 | 1995-11-30 | UNITED STATES OF AMERICA, represented by THE SECRETARY OF THE ARMY | Modele destine a l'essai de l'immunogenicite des peptides |
WO1996032119A1 (fr) * | 1995-04-14 | 1996-10-17 | Yeda Research And Development Co. Ltd. | Compositions pharmaceutiques comportant un copolymere peptidique de synthese et servant a la prevention des troubles dus a la reaction greffe contre hote |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4339431A (en) * | 1980-12-31 | 1982-07-13 | Colgate-Palmolive Company | Anticalculus oral composition |
FR2658076B1 (fr) * | 1990-02-12 | 1992-06-12 | Sanofi Sa | Composition cosmetique contenant des copolymeres d'aminoacides, utile comme agent hydratant. |
-
1999
- 1999-11-12 CA CA002355400A patent/CA2355400A1/fr not_active Abandoned
- 1999-11-12 EP EP99960378A patent/EP1128839A4/fr not_active Withdrawn
- 1999-11-12 AU AU17270/00A patent/AU775073C/en not_active Ceased
- 1999-11-12 WO PCT/US1999/027107 patent/WO2000027417A1/fr active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992002543A1 (fr) * | 1990-08-01 | 1992-02-20 | Cytel Corporation | Nouveaux peptides immunosuppresseurs |
WO1994026774A1 (fr) * | 1993-05-19 | 1994-11-24 | Cytel Corporation | Nouveaux traitements de maladies allergiques |
WO1995026980A2 (fr) * | 1994-04-01 | 1995-10-12 | Immulogic Pharmaceutical Corporation | Peptides haptines et leurs utilisations |
WO1995031997A1 (fr) * | 1994-05-20 | 1995-11-30 | UNITED STATES OF AMERICA, represented by THE SECRETARY OF THE ARMY | Modele destine a l'essai de l'immunogenicite des peptides |
WO1996032119A1 (fr) * | 1995-04-14 | 1996-10-17 | Yeda Research And Development Co. Ltd. | Compositions pharmaceutiques comportant un copolymere peptidique de synthese et servant a la prevention des troubles dus a la reaction greffe contre hote |
Non-Patent Citations (11)
Title |
---|
AHARONI RINA ET AL: "Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease.", IMMUNOLOGY LETTERS, vol. 58, no. 2, 1997, pages 79 - 87, XP002205821, ISSN: 0165-2478 * |
FRIDKIS-HARELI M. ET AL.: "Binding of random copolymers of three aminoacids to class II MHC molecules", INTERNATIONAL IMMUNOLOGY, vol. 11, no. 5, May 1999 (1999-05-01), pages 635 - 641, XP000893153 * |
FRIDKIS-HARELI M. ET AL.: "Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility comples molecules on living antigen-presenting cells - specificity and promiscuity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 91, 1994, WASHINGTON US, pages 4872 - 4876, XP000891508 * |
LI Q. ET AL.: "Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 342, 1998, pages 303 - 310, XP000893154 * |
SCHLEGEL P G ET AL: "A SYNTHETIC RANDOM BASIC COPOLYMER WITH PROMISCUOUS BINDING TO CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES INHIBITS T-CELLPROLIFERATIVE RESPONSES TO MAJOR AND MINOR HISTOCOMPATIBILITY ANTIGENS IN VITRO AND CONFERS THE CAPACITY TO PREVENT MURINE GRAFT-VERSUS-HOST DISEASE IN VIVO", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 10, 14 May 1996 (1996-05-14), pages 5061 - 5066, XP000578029, ISSN: 0027-8424 * |
See also references of WO0027417A1 * |
SELA M ET AL: "SUPPRESSIVE ACTIVITY OF COP-1 IN EAE AND ITS RELEVANCE TO MULTIPLE SCLEROSIS", BULL. INST. PASTEUR, vol. 88, 1990, pages 303 - 314, XP002926272 * |
TEITELBAUM D ET AL: "COPOLYMER 1 FROM THE LABORATORY TO FDA", ISRAEL JOURNAL OF MEDICAL SCIENCES, ISRAEL MEDICAL ASSOCIATION, TEL AVIV, IL, vol. 33, no. 4, April 1997 (1997-04-01), pages 280 - 284, XP002926268, ISSN: 0021-2180 * |
TEITELBAUM D ET AL: "CROSS-REACTIONS AND SPECIFICITIES OF MONOCLONAL ANTIBODIES AGAINST MYELIN BASIC PROTEIN AND AGAINST THE SYNTHETIC COPOLYMER1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 88, November 1991 (1991-11-01), pages 9528 - 9532, XP002949037, ISSN: 0027-8424 * |
TEITELBAUM D ET AL: "SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY A SYNTHETIC POLYPEPTIDE", EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, vol. 1, 1971, pages 242,244,246,248, XP002926270, ISSN: 0014-2980 * |
TEITELBAUM D ET AL: "SYNTHETIC COPOLYMER 1 INHIBITS HUMAN T-CELL LINES SPECIFIC FOR MYELIN BASIC PROTEIN", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 89, January 1992 (1992-01-01), pages 137 - 141, XP002924839, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
AU1727000A (en) | 2000-05-29 |
EP1128839A1 (fr) | 2001-09-05 |
AU775073B2 (en) | 2004-07-15 |
AU775073C (en) | 2007-05-03 |
WO2000027417A1 (fr) | 2000-05-18 |
CA2355400A1 (fr) | 2000-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1128839A4 (fr) | Compositions pharmaceutiques comprenant des copolymeres de peptides synthetiques et methodes de prevention et de traitement de la reaction du greffon contre l'hote (gvhd) et de la reaction de l'hote contre le greffon (hvgd) | |
IL127545A0 (en) | Compositions and methods for administering borrelia DNA | |
IL138533A0 (en) | Pharmaceutical compositions for prolonged peptide release and preparation method | |
ZA974268B (en) | Ethylene copolymers and blend compositions | |
HUP9900935A3 (en) | Antifungic and antibacterial peptide and process for preparation | |
EP1025165A4 (fr) | Procede et compositions renfermant des copolymeres polyphenoliques | |
IL138888A0 (en) | Pharmaceutical composition and combination preparation for immunosuppressive therapy | |
HUP0100082A3 (en) | Thrombin inhibitor, peptide derivatives, pharmaceutical compositions comprising thereof and their use | |
IL140742A0 (en) | Raloxifene and pharmaceutical composition comprising the same | |
IL125908A (en) | Peptides and pharmaceutical compositions comprising same | |
HUP0102109A3 (en) | Sweetener composition and uses thereof | |
SG71754A1 (en) | Copolymer and copolymer composition | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
IL125262A0 (en) | Synthetic peptides and pharmaceutical compositions comprising them | |
IL121329A (en) | Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides | |
ZA9710934B (en) | Compositions and methods for administering pneumococal dna | |
HUT74745A (en) | Pharmaceutical compositions containing p antagonist for treating pruritis, eye- and eyelid-acs and eye-and eyelid dysaesthesia | |
AU2001291994A1 (en) | Dipeptide ligands of the npff receptor for treating pain and hyperalgesia | |
EP0987942A4 (fr) | Composition pharmaceutique et procede d'utilisation | |
GB9606579D0 (en) | Pharmaceutical composition and methods for the manufacture thereof | |
GB9623962D0 (en) | Pharmaceutical composition | |
PL331283A1 (en) | Preparation for treating and/or preventing stupefaction | |
IL116976A0 (en) | Synthetic peptides and pharmaceutical compositions comprising them | |
IL137076A0 (en) | Bibapctitide-based pharmaceutical compositions for imaging and treating thrombi | |
EP0975610A4 (fr) | Composes pharmaceutiques a base de tripeptides et de tetrapeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010612 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07K 5/00 A, 7C 07K 7/00 B, 7A 61K 38/00 B, 7C 07K 16/00 B, 7G 01N 33/53 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020823 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20050818 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: YEDA RESEARCH AND DEVELOPMEMT CO., LTD. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: YEDA RESEARCH AND DEVELOPMENT CO., LTD. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20100427 |